C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/51 (2006.01) A61K 39/29 (2006.01) C07K 14/18 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2195312
Novel Hepatitis C E1 and E2 truncated polypeptides and complexes comprising these polypeptides, are disclosed. The polypeptides are C-termally truncated to remove all or a portion of their membrane spanning domains. Hence, the polypeptides are capable of secretion when expressed recombinantly.
Cette invention a pour objet de nouveaux polypeptides à troncature E1 et E2 de l'hépatite C et des complexes comprenant ces polypeptides. Les polypeptides sont tronqués au terminal C pour éliminer tout ou partie de leurs domaines recouvrant la membrane. Ces polypeptides sont par conséquent capables de sécrétion lorsqu'ils sont exprimés par recombinaison.
Houghton Michael
Selby Mark
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
Sim & Mcburney
LandOfFree
Novel hepatitis c e1 and e2 truncated polypeptides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel hepatitis c e1 and e2 truncated polypeptides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel hepatitis c e1 and e2 truncated polypeptides and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1492027